HCPCS Code Q5122: Injection, Pegfilgrastim-apgf (Nyvepria®), Biosimilar, 0.5 mg

Q5122 is the HCPCS code for pegfilgrastim-apgf (Nyvepria®), biosimilar, 0.5 mg, administered by subcutaneous injection.

Yes, but most billing occurs in the outpatient/physician office setting. Coverage and reimbursement rules may vary by payer.

Yes. Most payers require the drug name, strength, and NDC on claims to verify product-specific reimbursement.